Physical Therapy After Anti-spastic Treatment in Children With Cerebral Palsy
NCT ID: NCT00552721
Last Updated: 2009-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2007-10-31
2009-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Strength Training in Children With Spastic Diplegic and Hemiplegic Cerebral Palsy Receiving Botulinum Toxin
NCT04177186
Stretching and Strength Training for Improved Gait Function in Children With Spastic Cerebral Palsy
NCT02917330
Effect of Botulinum Toxin Type A Associated With Physical Therapy on Children With Spastic Cerebral Palsy
NCT03704155
Short Term Follow-up of a Botulinum Toxin Intervention in Children With Spastic Cerebral Palsy
NCT05126693
A Physical Therapy Program Targeting Lower Extremity Selective Motor Control in Children With Spastic Cerebral Palsy
NCT07310550
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Physical therapy with strength training.
Physical therapy with strength training
12 weeks of physical therapy after Botulinum-toxin treatment (two 45-min sessions/week) with an emphasis on strength training.
B
Physical therapy without strength training.
Physical therapy without strength training
12 weeks of physical therapy after Botulinum-toxin treatment (two 45-min sessions/week) without strength training.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical therapy with strength training
12 weeks of physical therapy after Botulinum-toxin treatment (two 45-min sessions/week) with an emphasis on strength training.
Physical therapy without strength training
12 weeks of physical therapy after Botulinum-toxin treatment (two 45-min sessions/week) without strength training.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* indication for anti-spastic treatment with Botulinum toxin
Exclusion Criteria
7 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hvidovre University Hospital
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Bandholm, MSc
Role: PRINCIPAL_INVESTIGATOR
Gait Analysis Laboratory, Department of Orthopedic Surgery, Hvidovre University Hospital
Stig Sonne-Holm, MD, DSc
Role: STUDY_CHAIR
Gait Analysis Laboratory, Department of Orthopedic Surgery, Hvidovre University Hospital
Bente R Jensen, PhD
Role: STUDY_CHAIR
Institute of Exercise and Sport Sciences, University of Copenhagen
Søren A Pedersen, MD
Role: STUDY_CHAIR
Hvidovre University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gait Analysis Laboratory, Department of Orthopedic Surgery, Hvidovre University Hospital
Hvidovre, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KF 02 323948
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.